Search is Powered by Google
Prostate / Prostate Cancer News

Transcorporal Artificial Urinary Sphincter Placement For Incontinence In High-risk Patients After Treatment Of Prostate Cancer

Main Category: Prostate / Prostate Cancer
Also Included In: Urology / Nephrology;  Cancer / Oncology
Article Date: 13 Oct 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:1 star

1 (1 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

UroToday.com - Our single center observational cohort study sought to examine the indications for the usage of transcorporal placement of artificial urinary sphincter (AUS) for incontinence after treatment for prostate adenocarcinoma.

Our study shows that after 2 years of follow-up the transcorporal approach to AUS placement is an effective primary or salvage incontinence therapy. We further analyzed this cohort by also including observational data for men treated for incontinence with a standard cuff placement AUS. What we found was that despite the higher incidence of prior radiation, multiple urethral surgeries, or both, the transcorporal approach fared as well as the standard. The reason for this finding presumably is related to the extra corporal tissue backing the dorsal urethra beneath the inflatable cuff. The need for this supportive backing we propose is secondary to the relatively de-vascularized urethra from prior insult that predisposes it to cuff erosion and infection.

One drawback to placement of a cuff through the corporal bodies is resultant erectile dysfunction. In our series, most if not all men were impotent from prior therapies thereby precluding this as a true concern. We did have one patient who went on to also receive a 3-piece inflatable penile prosthesis with good results.

We do not presume that transcorporal cuff placement is superior to the standard approach in all cases, but in carefully selected high-risk patients with erectile dysfunction it may well be a better choice.

Written by David S. Aaronson, MD, as part of Beyond the Abstract on UroToday.com

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2008 - UroToday




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Prostate Cancer Drug Breakthrough For Aggressive Form Of Disease
22 Jul 2008
A new trial drug called abiraterone has shown a high success rate at treating men with an aggressive, drug resistant, and often fatal form of prostate cancer. 70 to 80 per cent of the men on the trial experienced dramatic...


Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

Improving Health Care image Improving Health Care

Improvements are necessary to make sure Americans get the best quality health care and that money for this care is being spent as effectively as possible. Listen as experts -- both in government and in the private sector -- describe some of the steps taken to improve the health care system...

View more videos...